tiprankstipranks
Trending News
More News >
Town Health International Medical Group Ltd. (HK:3886)
:3886
Hong Kong Market
Advertisement

Town Health International Medical Group Ltd. (3886) AI Stock Analysis

Compare
1 Followers

Top Page

HK:3886

Town Health International Medical Group Ltd.

(3886)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 4o)
Rating:52Neutral
Price Target:
HK$0.50
▲(92.31% Upside)
The stock score is primarily impacted by financial performance challenges, particularly in profitability and cash flow management. Technical indicators suggest bearish momentum, and valuation is affected by a negative P/E ratio despite a high dividend yield.
Positive Factors
Strong Equity Base
A strong equity base provides financial stability and reduces the risk of insolvency, supporting long-term growth and investment capacity.
Ample Cash Reserves
Ample cash reserves ensure liquidity and the ability to invest in growth opportunities or weather economic downturns, supporting sustainable operations.
Revenue Diversification
Diversified revenue streams reduce dependency on a single source, enhancing resilience against sector-specific downturns and supporting stable growth.
Negative Factors
Profitability Challenges
Negative net income indicates ongoing profitability issues, which can hinder reinvestment in the business and affect long-term viability.
Inconsistent Cash Flow
Inconsistent cash flow can lead to liquidity issues, limiting the company's ability to fund operations and invest in growth, affecting stability.
Rising Leverage
Rising leverage increases financial risk, potentially leading to higher interest costs and reduced financial flexibility, impacting long-term sustainability.

Town Health International Medical Group Ltd. (3886) vs. iShares MSCI Hong Kong ETF (EWH)

Town Health International Medical Group Ltd. Business Overview & Revenue Model

Company DescriptionTown Health International Medical Group Ltd. (3886) is a leading provider of comprehensive healthcare services based in Hong Kong. The company operates in multiple sectors including outpatient services, hospital management, and telemedicine, offering a range of core products and services that cater to the evolving healthcare needs of its clients. Town Health focuses on delivering high-quality medical care, preventive health services, and wellness programs, leveraging technology to enhance patient access and outcomes.
How the Company Makes MoneyTown Health International Medical Group Ltd. generates revenue through several key streams. The primary source of income comes from outpatient services, where the company charges patients for consultations, diagnostic tests, and treatment plans. Additionally, Town Health earns revenue from its partnerships with hospitals and clinics, providing management services and sharing in the profits generated from patient care. Telemedicine services also contribute to revenue by enabling consultations and follow-ups via digital platforms, appealing to a broader patient base. Moreover, the company may receive income from health insurance reimbursements, as well as from corporate health programs and wellness initiatives offered to businesses. Strategic alliances with healthcare providers and insurers further enhance its market reach and profitability.

Town Health International Medical Group Ltd. Financial Statement Overview

Summary
The company shows moderate revenue growth but faces profitability challenges with negative net income. The balance sheet is strong with high equity and liquidity, though cash flow management is concerning due to inconsistent free cash flow.
Income Statement
60
Neutral
The revenue has shown moderate growth from 2020 to 2024, with a notable dip in gross profit margin from 2023 to 2024. The company has experienced negative net income in the recent years, indicating profitability challenges. EBIT and EBITDA margins are also under pressure, suggesting operational inefficiencies.
Balance Sheet
70
Positive
The company maintains a strong equity base with a favorable equity ratio. However, the debt-to-equity ratio has increased slightly over the years, signaling rising leverage. Despite this, the company has ample cash reserves, enhancing financial stability.
Cash Flow
50
Neutral
There is a lack of consistent positive free cash flow growth with significant fluctuations over the years. The operating cash flow has been insufficient to cover net income, indicating potential liquidity issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.82B1.83B1.83B1.54B1.48B1.07B
Gross Profit468.01M487.39M501.95M414.45M471.26M284.58M
EBITDA140.81M160.68M53.50M237.57M219.79M-97.78M
Net Income-143.30M-203.70M-194.21M15.29M22.01M-281.04M
Balance Sheet
Total Assets4.10B4.13B4.50B4.75B4.73B4.58B
Cash, Cash Equivalents and Short-Term Investments1.38B1.40B1.20B1.35B1.89B1.82B
Total Debt262.47M357.62M456.94M475.02M117.97M139.88M
Total Liabilities666.65M746.56M881.82M896.09M504.94M456.51M
Stockholders Equity3.01B2.98B3.24B3.49B3.86B3.81B
Cash Flow
Free Cash Flow172.04M206.11M229.79M-5.46M151.00M3.75M
Operating Cash Flow213.08M244.83M247.53M31.73M170.95M39.05M
Investing Cash Flow291.15M164.29M-20.95M587.77M-261.67M-742.86M
Financing Cash Flow-182.29M-235.72M-151.07M-518.45M-90.80M-93.68M

Town Health International Medical Group Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.26
Price Trends
50DMA
0.27
Negative
100DMA
0.27
Negative
200DMA
0.26
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
43.75
Neutral
STOCH
75.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3886, the sentiment is Neutral. The current price of 0.26 is above the 20-day moving average (MA) of 0.26, below the 50-day MA of 0.27, and above the 200-day MA of 0.26, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 43.75 is Neutral, neither overbought nor oversold. The STOCH value of 75.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:3886.

Town Health International Medical Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
HK$601.91M7.295.33%7.73%0.47%50.46%
66
Neutral
HK$1.54B5.3120.47%4.64%-3.56%-17.45%
56
Neutral
HK$827.78M5.6930.40%2.30%
52
Neutral
HK$1.86B-12.97-4.66%0.47%-0.55%45.36%
52
Neutral
HK$1.10B42.301.27%-4.30%13.83%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
45
Neutral
HK$1.30B-3.59%1.95%-4.09%-1242.31%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3886
Town Health International Medical Group Ltd.
0.26
0.02
8.33%
HK:9960
Kindstar Globalgene Technology, Inc.
1.22
0.09
7.96%
HK:1526
Rici Healthcare Holdings Ltd.
0.97
-0.21
-17.80%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
2.07
0.24
13.11%
HK:3869
Hospital Corporation of China Ltd
6.00
-0.70
-10.45%
HK:6639
Arrail Group Ltd.
1.83
-1.19
-39.40%

Town Health International Medical Group Ltd. Corporate Events

Town Health Updates on Profit Guarantee Proceedings
Sep 8, 2025

Town Health International Medical Group Ltd. has updated its shareholders on the ongoing proceedings related to a profit guarantee concerning its acquisition of Central Medical Holdings Limited. The company identified HK$5,000,000 in transactions that should be excluded from the Target Group’s operational profit for the financial year ended 31 March 2023. Consequently, Town Health is claiming an additional HK$75,000,000 due to the non-satisfaction of the performance target, raising the total claim amount to HK$172,956,690. The proceedings are still ongoing, and the company will provide further updates as necessary.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025